Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis. - Wikidata - wikimedia - TriplyDB

Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.

Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.

http://www.wikidata.org/entity/Q43843519

about

Tumor metastasis to bone Human desmoid fibroblasts: matrix metalloproteinases, their inhibitors and modulation by Toremifene Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer Targeting bone physiology for the treatment of metastatic prostate cancer Mineral density volume gradients in normal and diseased human tissues A novel MMP-2 inhibitor 3-azidowithaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular Par-4 Chemically modified non-antimicrobial tetracyclines are multifunctional drugs against advanced cancers Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target Prostate cancer in bone: importance of context for inhibition of matrix metalloproteinases Activation of AMP-activated protein kinase by 3,3'-Diindolylmethane (DIM) is associated with human prostate cancer cell death in vitro and in vivo Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression Tumor-stromal interactions in bone metastasis.Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells.Osteoclast-derived matrix metalloproteinase-9 directly affects angiogenesis in the prostate tumor-bone microenvironment.Development of a nomogram model predicting current bone scan positivity in patients treated with androgen-deprivation therapy for prostate cancer.Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis.Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer.Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.Multifunctional role of matrix metalloproteinases in multiple myeloma: a study in the 5T2MM mouse model.Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis.Modulation of prostate cancer growth in bone microenvironments.Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth.Hibiscus sabdariffa Leaf Extract Inhibits Human Prostate Cancer Cell Invasion via Down-Regulation of Akt/NF-kB/MMP-9 Pathway Association between MMP-2 expression and prostate cancer: A meta-analysis The IGR-CaP1 xenograft model recapitulates mixed osteolytic/blastic bone lesions observed in metastatic prostate cancer A role for endogenous reverse transcriptase in tumorigenesis and as a target in differentiating cancer therapy.Twist-related protein 1-mediated regulation of mesenchymal change contributes to the migration and invasion of cervical cancer cells Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach.Proteases as modulators of tumor-stromal interaction: primary tumors to bone metastases.Understanding and targeting osteoclastic activity in prostate cancer bone metastases.Dysregulation of miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to the metastasis of prostate cancer.The role of the EGFR signaling in tumor microenvironment.ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis.Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis.Breaking down bone: new insight into site-specific mechanisms of breast cancer osteolysis mediated by metalloproteinases.MMP16 is a marker of poor prognosis in gastric cancer promoting proliferation and invasion.Assessment of the potential of pathological stains in human prostate cancer.

P2860

Q21195416-52EEBCC6-2313-4E04-89CC-6117E8D81B01 Q24803335-8F69AE09-132E-4FD3-93EF-03BCC1B4644F Q24807354-E28189C0-8E88-42B0-90E8-2836B756F2E8 Q26863249-20C9A755-419F-4B74-B9EA-4B4BE10540C1 Q27310791-8DC3D5E5-3E53-4794-92FB-F32A568FB3B0 Q27321296-509F8BFD-431F-43A3-97AA-294CEEFA4556 Q27694500-68377DE0-FB64-48AD-B683-F97775D8DE8F Q28209528-6D538389-6BF8-4E15-8964-D33272E187AF Q28259937-358BA75E-28F8-4057-B11C-0EC6E4B8C26D Q28344383-5870CB4B-2779-4804-BFF3-10F7F8E3F8F5 Q28484287-4F554D2B-48C0-492F-8C0E-331EFE49C99B Q33918409-3764E1EF-3D02-4D8F-8337-4EDD1F2ED8F4 Q34022223-78D09F66-0CFE-47B0-83B0-93B5A1DF453B Q34057949-3C1748CC-5A5C-45D6-9B0F-37193F507F61 Q34159609-1A36EFCB-1A21-451B-9B8E-9AF4B828638A Q34406622-CDE35953-F077-4862-B5CC-928CFA4DAA59 Q34549787-2041AAA1-B488-4C44-942A-E0E7D6BC7557 Q34768332-0082C0C9-EE9E-498E-B6DA-AB922E7BF5C5 Q34770095-959A2946-247F-4D19-AFC4-CB6088E4497A Q35083825-49E54E6D-0702-415E-A656-7E996005C5A9 Q35103092-2FC1721B-1A5A-47D6-8D83-E06E0D86B2B0 Q35147059-9C15472A-B901-4A5B-AECF-56DB7441BE68 Q35678554-63E38947-68D6-4779-A7E2-A7F8226331D7 Q35855547-9B4CE3C7-5A0E-48FD-9869-A83D469B6F4B Q35894923-3910B5D5-BD3B-4970-A03A-64CB660512DA Q35928166-D3E08028-64EE-40B5-A642-584D56CD0C1A Q36062138-D7767933-17F1-4535-AB39-BE46E06F279C Q36263207-90C39B68-F221-4E8A-9C71-4F58416DF062 Q36336372-CDE3DFC0-47B4-450F-9FCF-C9B75B84CB01 Q36512574-1E99587A-35AB-475F-83D0-893F99FE6E0E Q36707418-E7169C5C-6A2F-4E60-A538-EC50CDA1C172 Q36759374-E7D0EC20-B61E-42F9-A76C-D8923A776640 Q36845839-9F48C297-830C-4BD8-9AA3-FBD66509E936 Q36951215-0E0044DE-F8FE-4384-A36A-E6820B92412C Q37302910-B2D63A46-76DB-4CE3-AEB6-626DFF37E385 Q37316559-1664B8B2-1452-48CB-BC77-72360302E6D0 Q37350475-A3940DF0-29BC-4ADB-B013-FEE46D5B4A22 Q37362838-5BF58991-BB1B-4230-AD1D-594422352E9D Q37588381-AA678FC8-E3C3-4543-AF1F-F6F119544BA6 Q37611912-905E5F5C-E965-4DA2-B67D-814BC41C681E

P2860

Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.

http://www.wikidata.org/entity/Q43843519

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Matrix metalloproteinase activ ...... ostate cancer bone metastasis.

@en

Matrix metalloproteinase activ ...... ostate cancer bone metastasis.

@nl

type

label

Matrix metalloproteinase activ ...... ostate cancer bone metastasis.

@en

Matrix metalloproteinase activ ...... ostate cancer bone metastasis.

@nl

prefLabel

Matrix metalloproteinase activ ...... ostate cancer bone metastasis.

@en

Matrix metalloproteinase activ ...... ostate cancer bone metastasis.

@nl

P1433

Q43843519-F6210AA3-8DA3-4B86-ADC3-005D00657C58

P1476

Q43843519-FC92060F-DB33-4DC6-9F85-26ACB5F77F1E

P2093

Q43843519-168CFBA4-2DD2-4012-9A39-ADEBAF13B4FD

Q43843519-32C380B8-954E-4EA9-BEDF-D20BC53A95D4

Q43843519-5F6142B9-C7D3-412A-B26A-3B67F7FC2818

Q43843519-93ADF9FA-810B-4A10-984E-62DCFF4EEB81

Q43843519-A80B2046-EA4D-443F-8B85-D3239F2D542A

Q43843519-B1441553-8898-4C11-AA94-A8812527F520

Q43843519-D5A7F103-D5C9-4478-9309-78BA0442D561

Q43843519-FB5A9D77-0F0F-45BC-891C-2F3645FCB540

Q43843519-FF655507-42A3-4440-83DC-5322BA2A0651

Q43843519-FF7726E8-F502-4A95-BA40-C08312B071D1

P304

Q43843519-C7A3F9F4-8518-4CD3-BCA9-A9E0842B0811

P31

Q43843519-3AAC128F-80A7-4E94-B555-4C850C0D99D8

P356

Q43843519-A8BC749B-6E7E-4398-95D5-01231C10243E

P407

Q43843519-0E6E39A8-985C-4204-8F1C-01BC93C59614

P433

Q43843519-B9A293B7-CEBE-445B-B849-503DAFC5B13C

P478

Q43843519-F1D0475D-B632-4860-B186-88A40ACA159C

P577

Q43843519-5D9F7F73-AC41-4503-AC22-DB3386B58A1B

P5875

Q43843519-63661928-6858-49D9-9C0F-AC446B155749

P698

Q43843519-E4A4D743-9A8B-4DD7-A503-F8151A144EB4

P356

P1433

Journal of the National Cancer Institute

P1476

Matrix metalloproteinase activ ...... ostate cancer bone metastasis.

@en

P2093

Bijan Shekarriz

http://www.w3.org/2001/XMLSchema#string

Chadwick Mullins

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Nemeth

http://www.w3.org/2001/XMLSchema#string

Jyoti Upadhyay

http://www.w3.org/2001/XMLSchema#string

Michael Herzog

http://www.w3.org/2001/XMLSchema#string

Michael L Cher

http://www.w3.org/2001/XMLSchema#string

Mingxin Che

http://www.w3.org/2001/XMLSchema#string

Rafael Fridman

http://www.w3.org/2001/XMLSchema#string

Rafid Yousif

http://www.w3.org/2001/XMLSchema#string

Sunita Bhagat

http://www.w3.org/2001/XMLSchema#string

P304

17-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/94.1.17

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11585182

http://www.w3.org/2001/XMLSchema#string

P698

11773278

http://www.w3.org/2001/XMLSchema#string